Appointment of Director
Lyka Labs Ltd has informed BSE that at the Board Meeting held on March 29, 2012, the Board of Directors have appointed Mr. V. Shanbhag as Director of the Company.03-04-2012
Appointment of Director
Lyka Labs Ltd has informed BSE that at the Board Meeting held on March 29, 2012, the Board of Directors have appointed Mr. V. Shanbhag as Director of the Company.Outcome of Board Meeting
Lyka Labs Ltd has informed BSE that the Board of the Directors of the Company at its meeting held on March 29, 2012, the Board has deferred transfer / sale of Company's R&D; Division to its wholly owned subsidiary Company.Board Meeting on March 29, 2012
Lyka Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 29, 2012 to consider transfer / sale of the Company's R&D; Centre to its wholly owned subsidiary Company.Financial Results for Dec 31, 2011
Lyka Labs Ltd has informed BSE about the Financial Results for the period ended December 31, 2011.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Nehal N Gandhi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE:Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Kunal N Gandhi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEName of the Target Company (TC) : Lyka Labs LtdName of the Promoter(s) on whose shares encumbrance was created/ invoked/ released : Kunal N GandhiDate of reporting : December 28, 2011...Updates - Agreement for Transfer of Know How/ Technology
Lyka Labs Ltd has informed BSE that the Company has recently entered into a Technology Transfer Agreement with a Pharma Company based in Republic of Turkey for a lyophilized formulation, for a. consideration of US $ 2,50,000 and Royalty for five years.Technical Assistance Agreement
Lyka Labs Ltd has informed BSE that the Company has entered into a "Technical Assistance Agreement" for "Lyophilized Formulations" with a Company based at Indonesia.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Nehal N Gandhi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEName of the Target Company (TC) : Lyka Labs LtdName of the Promoter(s) on whose shares encumbrance was created/ invoked/ released : Nehal N GandhiDate of reporting : November 04, 2011...Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Narendra I Gandhi (HUF) has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEName of the Target Company (TC) : Lyka Labs LtdName of the Promoter(s) on whose shares encumbrance was created/ invoked/ released : Narendra I Gandhi (HUF)Date of reporting : November 17, 2011...